Other studies have targeted xCT using salazosulfapyridine and protein kinase C alpha (PKCα) inhibitors to reduce intracellular GSH levels and promote ferroptosis in neuroblastoma stem cells (139). This evidence concerns the gene PRKCA and neuroblastoma.